Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,170
Closed -$18.1K 295
2024
Q2
$18.1K Hold
27,170
0.01% 89
2024
Q1
$35.3K Sell
27,170
-76,000
-74% -$79.6K 0.01% 278
2023
Q4
$59.1K Sell
103,170
-8,500
-8% -$5.87K 0.01% 260
2023
Q3
$84.2K Buy
+111,670
New +$84.9K 0.02% 249
2023
Q2
Sell
-108,970
Closed -$82.5K 263
2023
Q1
$82.5K Sell
108,970
-9,000
-8% -$8.36K 0.02% 247
2022
Q4
$113K Sell
117,970
-25,380
-18% -$35.9K 0.03% 260
2022
Q3
$313K Buy
143,350
+9,800
+7% +$33.8K 0.09% 186
2022
Q2
$467K Sell
133,550
-27,000
-17% -$101K 0.13% 137
2022
Q1
$809K Buy
160,550
+700
+0.4% +$3.55K 0.2% 99
2021
Q4
$1M Buy
159,850
+34,830
+28% +$238K 0.26% 84
2021
Q3
$994K Buy
125,020
+14,420
+13% +$119K 0.28% 78
2021
Q2
$828K Buy
110,600
+50,000
+83% +$349K 0.24% 88
2021
Q1
$367K Buy
60,600
+29,800
+97% +$229K 0.12% 165
2020
Q4
$176K Buy
30,800
+12,100
+65% +$77K 0.06% 219
2020
Q3
$124K Buy
+18,700
New +$167K 0.05% 207

Other funds holding VXRT

Private Portfolio Partners's VXRT Position: Q3 2024 in Review

Private Portfolio Partners sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 27,170 shares — an estimated $18.1K sold.

Private Portfolio Partners first reported a position in VXRT in Q3 2020 and held it in 15 quarters. The position peaked at $1M in Q4 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • Private Portfolio Partners reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
  • Private Portfolio Partners sold 27,170 Vaxart shares in Q3 2024, an estimated $18.1K.
  • Private Portfolio Partners first reported a position in Vaxart in Q3 2020 and held it in 15 quarters.
  • Private Portfolio Partners's Vaxart position peaked at $1M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on Private Portfolio Partners's 13F filing for Q3 2024, filed 12 Nov 2024.